Cargando…
Gastric cancer peritoneal metastasis related signature predicts prognosis and sensitivity to immunotherapy in gastric cancer
Gastric cancer peritoneal metastases (GCPM) is a leading cause of GC‐related death. Early detection of GCPM is critical for improving the prognosis of advanced GC. Differentially expressed genes (DEGs) were identified in the GSE62254 database to distinguish between GCPM and non‐GCPM. The gastric can...
Autores principales: | Sun, YuQin, Chen, YueQing, Zhuang, Wei, Fang, ShunYong, Chen, QiuXian, Lian, MingQiao, Lv, ChenBin, Weng, JianMing, Wei, Ran, Lin, Yao, Cai, LiSheng, Wang, QingShui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660625/ https://www.ncbi.nlm.nih.gov/pubmed/37605453 http://dx.doi.org/10.1111/jcmm.17922 |
Ejemplares similares
-
Research status on immunotherapy trials of gastric cancer
por: Liang, Chao, et al.
Publicado: (2021) -
High DAPK1 Expression Promotes Tumor Metastasis of Gastric Cancer
por: Wang, Qingshui, et al.
Publicado: (2022) -
Epigenetic silenced miR‐125a‐5p could be self‐activated through targeting Suv39H1 in gastric cancer
por: Cai, Mingzhi, et al.
Publicado: (2018) -
Prognostic Significance of PD-L1 Expression in Gastric Cancer Patients with Peritoneal Metastasis
por: Chen, Xiao-Jiang, et al.
Publicado: (2023) -
Molecular Mechanisms and Potential Rationale of Immunotherapy in Peritoneal Metastasis of Advanced Gastric Cancer
por: Kang, Donghoon, et al.
Publicado: (2022)